user avatar
QIAGEN
@QIAGEN
#QIAGEN is a leading provider of molecular Sample to Insight solutions. Impressum: qiagen.com/de/trademarks-
Hilden, Germany
Joined May 2009
Posts
  • Pinned
    user avatar
    We are excited to announce a new collaboration with @NVIDIAHealth to advance AI-driven drug discovery. Learn more 👉 tinyurl.com/3kwfrc3h #QGEN #QIA #NVDA
  • user avatar
    Check out the great time we had at #ASCO17 in Chicago and enjoy the flashback! x.com/i/moments/8724…
  • user avatar
    Did you know that there are 7,000 rare diseases? #RareDiseaseDay #ShowYourRare Find out more: bit.ly/2tJ76hA
  • user avatar
    We are dramatically ramping up global production capacity for RNA extraction kits for use in detection of SARS-CoV-2 coronavirus #COVID19
  • user avatar
    “Nothing else matches the consistency, quality and concentration of RNA that I get from these kits.” – Asha Palat, department of biology and biochemistry at the University of Houston
  • user avatar
    Did you know that 1 out of 20 people have a rare disease? #RareDiseaseDay #ShowYourRare #MyRare
  • user avatar
    The World Health Organization estimates that a startling one in four people worldwide is infected with tuberculosis. Learn how the Omani government is pioneering #TB Management. #EndTB #StopTB
  • user avatar
    “Treating latent TB means fewer drugs, fewer side effects, and shorter times for therapy.” - Dr. Eskild Petersen, Ministry of Health, Oman | Learn how ⬇️
  • user avatar
    Nasim fled the war in Syria and works now at our molecular diagnostic products department. Find out more: fal.cn/Qg4M
  • user avatar
    “This strategic step with Thermo Fisher will enable us to enter a promising new era and will give our employees the opportunity to have an even greater impact." - Thierry Bernard, interim CEO of QIAGEN N.V. and SVP, head of the molecular diagnostics business area
  • user avatar
    A pioneer in the field of immunotherapy discovers and manipulates specific immune cells to defend against cancer using QIAGEN’s next-generation sequencing technologies:
  • user avatar
    “My research targets ways to monitor the immune responses of cancer patients treated with anti PD-1 antibodies, as well as the best selection of T-cells for adoptive cell transfer.” - Nathalie Labarrière, French Institute of Health and Medical Research, University of Nantes.
  • user avatar
    We support the integration of #refugees into the local labor market. Meet our interns Nasim, Mhamud and Fadi vimeo.com/202928404
  • user avatar
    ⚡️ Happy to share our favorite moments from #AMPGlobal2017! Browse through our updatesd from the event: x.com/i/moments/8499…